‪#‎SSc16‬ – Exclusive Interview with Colin Meyer, Reata Pharmaceuticals

Recent Posts

• Dexamethasone reduces inflammation, scarring in SSc mouse model: Study
• Survival improves for SSc-PAH patients on combination therapy
• Combination drug therapy boosts lung, skin health in SSc patients
• On choosing medicine’s side effects over scleroderma progression
• Telerehabilitation improves hand mobility in scleroderma women
• Molecular pathway ID’d as key driver of scarring in scleroderma
• Limited hand function disrupts daily life for people living with SSc
• Coping with loss is part of living with scleroderma
• CAR T-cell therapy eases SSc symptoms, early trial data show
• Milk-derived particles may offer treatment path for SSc fibrosis